Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-10-15
1993-08-03
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514826, 540599, A61K 3155, C07D41300
Patent
active
052329194
ABSTRACT:
An embonic acid salt of azelastine is disclosed which does not possess the bitter taste of azelastine, and which therefore is suitable for orally administered formulations.
REFERENCES:
patent: 2925417 (1960-02-01), Elslager et al.
patent: 3813384 (1974-05-01), Vogelsang et al.
patent: 4704387 (1987-11-01), Engel et al.
J. Allergy Clin. Immunol. (Nov. 1988) p. 801, Multicenter, Double Blind, . . . , Efficacy & Safety Trial of Azelastine, Chlorpheniramine & Placebo . . . Weiler M. D.
M. Negwer: Org.-Chem. Drugs and Their Synonyms, vol. III, No. 6496, 1987, p. 1145.
German Search Report re: P 37 38 681.6.
Engel Jurgen
Sauerbier Dieter
Scheffler Gerhard
Asta Pharma Aktiengesellschaft
Schenkman Leonard
LandOfFree
Azelastine embonate and compositions which contain it does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azelastine embonate and compositions which contain it, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azelastine embonate and compositions which contain it will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2270443